Number of items: 3.
Article
Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities. (2021)
Hasumati Rahalkar,
Alan Sheppard,
Gustavo Mendes Lima Santos,
Chitralekha Dasgupta,
Sonia Mayra Perez-Tapia,
Carlos A. Lopez-Morales
and
Sam Salek
Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices. (2021)
Hasumati Rahalkar,
Alan Sheppard
and
Sam Salek
Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study. (2021)
Hasumati Rahalkar,
Alan Sheppard,
Carlos Augusto Lopez-Morales,
Luciano Lobo
and
Sam Salek
This list was generated on Thu May 28 02:05:48 2026 BST.